- The trend backdrop is active with a 10-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
INIFY
OSL
Week ended 07 Aug 2026
Weekly Investor Report
INIFY Laboratories AB · Healthcare · Diagnostics & Research
Latest close
7.95 NOK
-0.6%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 51.3% above the Trend Line and sits at 95.1% of its 52-week range. The latest completed week returned -0.6%, after a 0.6% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.
Setup score
54
out of 100
Latest Close
7.95 NOK
7 Aug 2026
1W Return
-0.6%
latest completed week
4W Return
0.6%
short-term follow-through
12W Return
100.8%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
0.1x
vs 13-week average
- Next-week expectancy is negative at 31.51% based on similar historical setup states.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.6%
Latest completed week; four-week move 0.6%.
Indicator stack
45/71
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 31.51%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 51.3% above the Trend Line and sits at 95.1% of its 52-week range. The latest completed week returned -0.6%, after a 0.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9212-week average 0.52
12-week confirmation
Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.92Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.6% over four weeks, 100.8% over 12 weeks, and 27.2% over one year. The current trend has remained active for 10 consecutive weeks.
Performance by holding period
Active trend streak10 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.19Latest activity-pressure read.
Pressure change0.5%Four-week change in activity pressure.
Leadership38.22Latest relative-leadership reading.
RS change-15.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.0%Distance below the 52-week high.
13-week volatility16.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher9 of 2611 weeks finished lower.
Best week+52.4%Week of 12 Jun.
Worst week-22.2%Week of 3 Apr.
Latest week-0.6%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains2
Flat weeks6
Modest losses6
Sharp losses5
Recent vol16.8%13-week weekly-return volatility.
Base vol14.8%52-week weekly-return volatility.
Up/down split20/26Count of positive and negative weeks in the 52-week window.
Average skew14.6% / -8.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorNO Healthcare
4-week rank14 / 24
Group average4.3%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD37.5%positive activity pressure
RS29.2%positive relative leadership
Four-week leaders
IndustryNO Diagnostics & Research
4-week rank1 / 1
Group average0.6%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS100.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape49/100
Trend, activity pressure, participation, and risk combine to a 49/100 tape read.
Indicator analysis81/100Latest 12-week confirmation: trend 10/12, activity pressure 12/12, relative leadership 9/12.
Activity pressure 0.92; No reversal markers Next-Week ExpectancyNegative 31.51%Next-week expectancy is negative with a 31.51% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 7.95 NOK | -0.6% | 5.25 NOK | 7.39 NOK | 1.19 | 38.22 | 649 | On |
| 31 Jul 2026 | 8.00 NOK | 0.0% | 5.13 NOK | 7.44 NOK | 1.24 | 39.71 | 23.6K | On |
| 24 Jul 2026 | 8.00 NOK | 0.0% | 5.02 NOK | 7.48 NOK | 1.21 | 40.48 | 6.6K | On |
| 17 Jul 2026 | 8.00 NOK | 1.3% | 4.87 NOK | 7.52 NOK | 1.20 | 44.77 | 9.2K | On |
| 10 Jul 2026 | 7.90 NOK | 0.0% | 4.72 NOK | 7.56 NOK | 1.18 | 45.18 | 1.9K | On |
| 3 Jul 2026 | 7.90 NOK | 0.0% | 4.58 NOK | 7.61 NOK | 1.19 | 44.90 | 629 | On |
| 26 Jun 2026 | 7.90 NOK | -1.2% | 4.44 NOK | 7.66 NOK | 1.18 | 48.79 | 556 | On |
| 19 Jun 2026 | 8.00 NOK | 0.0% | 4.34 NOK | 7.67 NOK | 1.21 | 46.87 | 527 | On |
| 12 Jun 2026 | 8.00 NOK | 52.4% | 4.19 NOK | 7.67 NOK | 0.88 | 44.02 | 8.0K | On |
| 5 Jun 2026 | 5.25 NOK | 5.8% | 4.08 NOK | 7.68 NOK | 0.57 | -5.89 | 6.6K | On |
| 29 May 2026 | 4.96 NOK | 37.0% | 4.08 NOK | 7.69 NOK | 0.41 | -11.83 | 90.3K | Off |
| 22 May 2026 | 3.62 NOK | -8.6% | 4.11 NOK | 7.71 NOK | 0.09 | -37.74 | 11.4K | Off |
| 15 May 2026 | 3.96 NOK | -0.5% | 4.17 NOK | 7.74 NOK | 0.16 | -32.35 | 710 | Off |
| 8 May 2026 | 3.98 NOK | 10.6% | 4.24 NOK | 7.77 NOK | 0.24 | -31.58 | 42.7K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.